Jag Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $26.7M | Buy |
22,275
+18
| +0.1% | +$18.4K | 2.5% | 11 |
|
|
2026
Q1 | $20.5M | Buy |
22,257
+1,206
| +6% | +$1.22M | 2.3% | 14 |
|
|
2025
Q4 | $22.6M | Buy |
21,051
+7,481
| +55% | +$7.15M | 2.45% | 12 |
|
|
2025
Q3 | $10.4M | Sell |
13,570
-11,047
| -45% | -$8.22M | 1.13% | 28 |
|
|
2025
Q2 | $19.2M | Buy |
24,617
+273
| +1% | +$212K | 2.15% | 16 |
|
|
2025
Q1 | $20.1M | Buy |
24,344
+8,871
| +57% | +$7.38M | 2.68% | 12 |
|
|
2024
Q4 | $11.9M | Sell |
15,473
-12,100
| -44% | -$10M | 1.67% | 24 |
|
|
2024
Q3 | $24.4M | Buy |
27,573
+1,374
| +5% | +$1.24M | 2.95% | 10 |
|
|
2024
Q2 | $23.7M | Sell |
26,199
-226
| -0.9% | -$181K | 3.25% | 8 |
|
|
2024
Q1 | $20.6M | Sell |
26,425
-1,145
| -4% | -$815K | 2.91% | 9 |
|
|
2023
Q4 | $16.1M | Sell |
27,570
-4,340
| -14% | -$2.53M | 2.46% | 17 |
|
|
2023
Q3 | $17.1M | Buy |
31,910
+852
| +3% | +$439K | 2.07% | 16 |
|
|
2023
Q2 | $14.6M | Buy |
31,058
+6,549
| +27% | +$2.75M | 1.68% | 23 |
|
|
2023
Q1 | $8.42M | Sell |
24,509
-13,367
| -35% | -$4.51M | 1.09% | 32 |
|
|
2022
Q4 | $13.9M | Sell |
37,876
-3,743
| -9% | -$1.33M | 2.01% | 17 |
|
|
2022
Q3 | $13.5M | Sell |
41,619
-3,099
| -7% | -$982K | 1.88% | 16 |
|
|
2022
Q2 | $14.5M | Buy |
44,718
+43,403
| +3,301% | +$13M | 1.79% | 15 |
|
|
2022
Q1 | $246K | Sell |
1,315
-54,662
| -98% | -$14.1M | 0.02% | 193 |
|
|
2021
Q4 | $15.5M | Buy |
55,977
+3,002
| +6% | +$761K | 1.19% | 30 |
|
|
2021
Q3 | $12.2M | Buy |
52,975
+51,657
| +3,919% | +$12.7M | 0.95% | 32 |
|
|
2021
Q2 | $302K | Buy |
1,318
+3
| +0.2% | +$603 | 0.02% | 201 |
|
|
2021
Q1 | $246K | Buy |
+1,315
| New | +$257K | 0.02% | 204 |
|
|
2020
Q3 | – | Sell |
-1,701
| Closed | -$279K | – | 180 |
|
|
2020
Q2 | $279K | Hold |
1,701
| – | – | 0.03% | 147 |
|
|
2020
Q1 | $236K | Hold |
1,701
| – | – | 0.03% | 151 |
|
|
2019
Q4 | $224K | Buy |
+1,701
| New | +$197K | 0.03% | 185 |
|
|
2019
Q2 | – | Sell |
-157,962
| Closed | -$20.5M | – | 197 |
|
|
2019
Q1 | $20.5M | Buy |
157,962
+13,680
| +9% | +$1.66M | 3.34% | 5 |
|
|
2018
Q4 | $16.7M | Buy |
144,282
+10,105
| +8% | +$1.13M | 3.4% | 7 |
|
|
2018
Q3 | $14.4M | Buy |
+134,177
| New | +$13.4M | 2.36% | 19 |
|
|
2017
Q3 | – | Sell |
-2,575
| Closed | -$212K | – | 116 |
|
|
2017
Q2 | $212K | Hold |
2,575
| – | – | 0.04% | 108 |
|
|
2017
Q1 | $217K | Sell |
2,575
-2,250
| -47% | -$180K | 0.04% | 105 |
|
|
2016
Q4 | $355K | Buy |
+4,825
| New | +$359K | 0.07% | 106 |
|
Other funds holding LLY
SC
ONB
GIM
Jag Capital Management's LLY Position: Q2 2026 in Review
Jag Capital Management increased its Eli Lilly (LLY) stake by 0.08% in Q2 2026, buying an estimated $18.4K and bringing the position to 22,275 shares worth $26.7M. The position accounts for 2.5% of the portfolio, ranked #11.
Jag Capital Management first reported a position in LLY in Q4 2016 and has held it in 31 quarters since. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Jag Capital Management held 22,275 shares of Eli Lilly worth $26.7M as of Q2 2026.
- Jag Capital Management bought 18 Eli Lilly shares in Q2 2026, an estimated $18.4K.
- Eli Lilly made up 2.5% of Jag Capital Management's portfolio in Q2 2026, its #11 holding.
- Jag Capital Management first reported a position in Eli Lilly in Q4 2016 and has held it in 31 quarters since.
- 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Jag Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.